The susceptibility of 31 strains of Nocardia asteroides to various quinolones and beta-lactams, as well as coumermycin, amikacin, and minocycline, was determined by the agar dilution technique. Ciprofloxacin was the most active fluoroquinolone tested on a weight basis, as it inhibited approximately 50% of the isolates at achievable drug levels in serum. Ceftriaxone and cefpirome were the most active cephalosporins in this system with MICs of 8 ,ug/ml for 80% of strains tested. Imipenem, amikacin, and minocycline were the most effective agents tested.
The susceptibility of 31 strains of Nocardia asteroides to various quinolones and beta-lactams, as well as coumermycin, amikacin, and minocycline, was determined by the agar dilution technique. Ciprofloxacin was the most active fluoroquinolone tested on a weight basis, as it inhibited approximately 50% of the isolates at achievable drug levels in serum. Ceftriaxone and cefpirome were the most active cephalosporins in this system with MICs of 8 ,ug/ml for 80% of strains tested. Imipenem, amikacin, and minocycline were the most effective agents tested.
Nocardia asteroides is a pathogen in the immunologically incompetent and immunologically normal host (4, 15) . De- pending upon the site infection and the immunological status of the patient, this disease can be associated with extremely high mortality rates (14) .
Sulfonamides are the preferred therapy for many forms of nocardiosis, yet there are reports of patients unsuccessfully treated with these agents (5) . There are also patients who develop side effects, necessitating the withdrawal of these compounds. Other antimicrobial agents, such as amikacin and imipenem, as well as several newer beta-lactams, have shown activity against N. asteroides in vitro, as well as in an experimental model of cerebral nocardiosis (6, 7, 9, 10) . There are also reports of successful therapy with agents other than the sulfa compounds (3) .
A class of carboxyquinolones is being tested in a wide range of clinical settings, and these agents have been shown to have an extremely broad spectrum of activity against a variety of organisms, particularly the family Enterobacteriaceae (1, 11, 16) . These agents are inhibitors of DNA gyrase and are not subject to alteration or degradation by plasmid-mediated mechanisms. The present study was designed to determine if members of the carboxyquinolones, as well as several other antimicrobial agents, have in vitro activity against N. asteroides.
The in vitro susceptibility of 31 strains of N. asteroides to six quinolones, six cephalosporins, and other antimicrobial agents, was determined by the agar dilution technique. These strains were obtained from patients with a variety of forms of nocardial infections. All strains were identified by standard criteria.
A loopful of each isolate was placed in 50 ml of brain heart infusion broth and incubated in a rotary incubator. After 48 h, 1 ml of a homogeneous solution of N. asteroides was subcultured into another 50 ml of brain heart infusion broth. The organisms were in a homogeneous suspension, and little visible or microscopic clumping was observed. These cultures were incubated for 72 h in a rotary incubator as described above. After this period of incubation, all flasks were turbid and the suspensions were homogeneous. Colony counts were assayed, and each culture contained between 107 and 109 CFU of N. asteroides per ml of broth. These suspensions were placed into the wells of a Steers replicator, * The activity of the antimicrobial agents used in this study against 31 strains of N. asteroides is shown in Table 1 . The carboxyquinolones used in this study generally had poor activity against our isolates. On a weight basis, ciprofloxacin was the most active quinolone, yet only 50% of the strains were inhibited by achievable drug concentrations in serum. The same was true for ofloxacin but at higher concentrations. These two agents differ in their peak concentrations in serum and other pharmacokinetic properties which may make them therapeutically equivalent (16; personal communication, William J. Novick, Jr., data on file, HoechstRoussel Pharmaceuticals, Inc.). The broad-spectrum cephalosporins showed variable activity against these isolates. Ceftriaxone and cefpirome had similar activity, as approximately 80% of the strains were inhibited by achievable drug concentrations in serum (13) . This is similar to the activity shown by cefotaxime as reported previously (7) . Aztreonam was inactive against these strains. Of the clavulanate antibiotics, only amoxicillin-clavulanic acid showed moderate activity, as it inhibited 50% of the isolates at <16 ,ug/ml. Coumermycin had activity similar to that of amoxicillinclavulanic acid. Minocycline, amikacin, and imipenem were There have been recent reports on the susceptibility of N. asteroides to newer antimicrobial agents alone and in combination (6) (7) (8) 10) . Studies have been necessary as a result of the failure of standard sulfonamide treatment in some patients and the intolerance to this type of therapy in others (3, 5) . Despite successful treatment in some patients, sulfa compounds do not appear to be bactericidal against many strains of N. asteroides. This lack of bactericidal activity may in part account for high mortality rates in the immunologically incompetent patient with certain forms of nocardiosis. This may also be the reason for the prolonged therapy needed to eradicate or continually suppress this organism. In the experimental model, there are other treatments based on susceptibility studies which proved to be superior to the sulfa compounds (9) . They are, specifically, amikacin and imipenem.
Early reports showed a lack of correlation between in vitro susceptibility and in vivo clinical efficacy (2, 12 
